|
⚲
|
| Keyboard |
| Samsara Biocapital LLC
✚
|
|
|---|---|
| CRD # | 288114 |
| SEC # | 801-113741 |
| CIK # | 0001744967 |
| AUM | 2,170.1 M (2026-06-26) |
| Employees | 31 (71% Investors, 0% Brokers) |
| Phone | 650-285-4270 |
| Address | |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Scholar Rock Holding Corp | 339.1 | ||
| Mineralys Therapeutics Inc | 159.0 | ||
| Alumis Inc | 139.8 | ||
| Septerna Inc | 75.7 | ||
| Allovir Inc | 74.7 | ||
| Spyglass Pharma Inc | 54.7 | ||
| Aquinox Pharmaceuticals Inc | 34.6 | ||
| Inventiva Sa | 28.8 | ||
| Aerovate Therapeutics Inc | 13.6 | ||
| VTV Therapeutics Inc | 11.8 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Samsara Opportunity Fund LP | [2026-03-31] | 98.0 M | 270.1 M |
| Offered $200,000,000 · Filed 2025-09-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $102,028,666 · Duration One year or less · Net Assets Decline to Disclose | ||||
| VC | SMSR B1 LP | [2023-03-31] | 149.3 M | |
| VC | 565 SPV I LP | 2020-03-30 | 0.0 M | |
| VC | Samsara Biocapital LP | [2017-03-20] | 310.1 M | 1,900.0 M |
| Offered $310,090,000 · Filed 2018-04-20 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Finder's Fee $20,000 · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 2.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 2.2 |
| By Discretionary | ||
| Discretionary | 3 | 2.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 2.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.2 | |
| United States Persons | 1.9 | |
| Total | 3 | 2.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Srinivas Akkaraju | Director | 28 | 3 | |
| Michael Dybbs | Director | 16 | 2 | |
| Abraham Bassan | Director | 5 | 2 | |
| Abrar Hussain | Executive Officer | 4 | 2 | |
| Samsara Biocapital GP LLC | Director | 2 | 2 | |
| Samsara Opportunity Fund GP LLC | Director | 1 | 1 | |
| Miran Ahmad | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001744967] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Comparable Firms | State | AUM |
|---|---|---|
|
Clearbridge Investments North America PTY Limited
✚
|
2,228.1 M | |
|
FS Structured Products Advisor LLC
✚
|
PA | 2,203.9 M |
|
Bell Asset Management Limited
✚
|
2,176.8 M | |
|
Lattice Strategies LLC
✚
|
PA | 2,153.5 M |
|
Lawley Retirement Advisors LLC
✚
|
NY | 2,130.1 M |
|
Sparx Asset Management Korea Co Ltd
✚
|
2,126.2 M | |
|
DoubleLine ETF Adviser LP
✚
|
FL | 2,125.6 M |
|
Velocity Capital Advisors LLC
✚
|
NY | 2,115.4 M |
|
New England Retirement Consultants LLC
✚
|
MA | 2,113.8 M |
|
Distillate Capital Partners LLC
✚
|
IL | 2,111.5 M |